Platform

circle_medical

Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis

CRAC Channels And Disease – From Human CRAC Channelopathies And Animal Models To Novel Drugs

CRAC channels as targets for drug discovery and development

Ca2+ signalling underlying pancreatitis

Scroll to Top